EntryPoint Capital’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$185K	Sell	13,232 -510	-4%	-$7.13K	0.09%	501
2025 Q1	$185K	Buy	+13,742	New	+$185K	0.08%	555
2024 Q3	–	Sell	-5,569	Closed	-$72.5K	–	1177
2024 Q2	$72.5K	Buy	+5,569	New	+$72.5K	0.11%	439